Merck Sharpe and Dohme (New Zealand) Limited, 17 October, Internet. Available from:, Accessed December 6, 2007
Merck Sharpe and Dohme (New Zealand) Limited. Fosamax (alendronate) data sheet; 17 October 2005. Internet. Available from: http://www.medsafe.govt.nz/ profs/datasheet/f/fosamaxtab.htm. Accessed December 6, 2007.
Adverse Drug Reactions Advisory Committee. Bisphosphonates and ocular inflammation. Aust Adv Drug Reactions Bull 2004;23, no. 2. [Internet. Accessed November 21, 2007.] Available from: www.tga.gov.au/adr/aadrb/aadr0404.htm#3
Adverse Drug Reactions Advisory Committee. Bisphosphonates and ocular inflammation. Aust Adv Drug Reactions Bull 2004;23, no. 2. [Internet. Accessed November 21, 2007.] Available from: www.tga.gov.au/adr/aadrb/aadr0404.htm#3
9
40649123486
The Uppsala Monitoring Centre. Alendronic acid and synovitis. Signal, March 2003. Restricted document. Contact the Uppsala Monitoring Centre for details; e-mail: info@who-umc.org.
The Uppsala Monitoring Centre. Alendronic acid and synovitis. Signal, March 2003. (Restricted document. Contact the Uppsala Monitoring Centre for details; e-mail: info@who-umc.org.
10
1842478230
Acute polyarthritis related to once weekly alendronate in a woman with osteoporosis [letter]
Gerster JC. Acute polyarthritis related to once weekly alendronate in a woman with osteoporosis [letter]. J Rheumatol 2004;31:829-30.
Persistent polyarticular synovitis after treatment with alendronate
English abstract in Reactions Weekly 16 June 2007, No. 1156, p. 7
Frederiksen L, Junker P, Brixen KT. Persistent polyarticular synovitis after treatment with alendronate. Ugeskrift for Laeger 2007;169:1583-4. (English abstract in Reactions Weekly 16 June 2007, No. 1156, p. 7)